Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Therapeutic and nontherapeutic responses
ADR ID BADD_A04263
ADR Hierarchy
08      General disorders and administration site conditions
08.06      Therapeutic and nontherapeutic effects (excl toxicity)
08.06.01      Therapeutic and nontherapeutic responses
Description Not Available
MedDRA Code 10043409
MeSH ID Not Available
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Not Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01257Letrozole0.004004%
BADD_D01258Leucovorin0.007683%
BADD_D01260Leuprolide acetate0.716300%
BADD_D01262Levalbuterol0.002908%
BADD_D01265Levetiracetam0.095572%
BADD_D01271Levocarnitine0.009487%
BADD_D01272Levocetirizine0.004949%
BADD_D01275Levofloxacin0.002062%
BADD_D01281Levonorgestrel0.777638%
BADD_D01282Levorphanol-
BADD_D01285Levothyroxine0.002490%
BADD_D01287Lidocaine0.003417%
BADD_D01290Lifitegrast0.147881%
BADD_D01292Linagliptin0.000825%
BADD_D01295Linezolid0.126786%
BADD_D01296Liothyronine0.012311%
BADD_D01300Lisinopril0.000036%
BADD_D01303Lithium carbonate0.008298%
BADD_D01304Lithium cation0.003706%
BADD_D01311Lomitapide0.000778%
BADD_D01317Loratadine0.004238%
BADD_D01318Lorazepam0.001253%
BADD_D01322Losartan0.002153%
BADD_D01324Loteprednol etabonate0.003444%
BADD_D01325Lovastatin0.000133%
BADD_D01326Loxapine--
BADD_D01328Lubiprostone0.006391%
BADD_D01330Lurasidone0.056304%
BADD_D01336Macitentan0.035826%
BADD_D01342Magnesium hydroxide0.038748%
The 14th Page    First    Pre   14 15 16 17 18    Next   Last    Total 31 Pages
ADReCS-Target
ADR Term Drug Name Target